Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

10. April 2026 07:14 ET | Quelle: Mordor Intelligence

Immunohistochemistry Market Led by Diagnostics Segment with 60%+ Share; Market Projected to Reach USD 4.42 billion by 2031, Mordor Intelligence Reports

Immunohistochemistry demand grows in oncology diagnostics and digital pathology as companies like Thermo Fisher, Roche, Agilent and Merck drive innovation.
07. April 2026 12:15 ET | Quelle: Research and Markets

Molecular Tumor Board Solutions Market Outlook 2026-2030 & 2035 with Competitor Market Share Data

Dublin, April 07, 2026 (GLOBE NEWSWIRE) -- The "Molecular Tumor Board Solutions Market Report 2026" has been added to ResearchAndMarkets.com's offering. The molecular tumor board solutions...
30. März 2026 05:05 ET | Quelle: Research and Markets

Non-Small Cell Lung Cancer (NSCLC) Global Market Trends and Regional Growth Insights 2026-2030: Rapid Adoption of Targeted Therapies and Immunotherapy Fuels Market Expansion, Reaching $70.8 Billion by 2030

Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Non-Small Cell Lung Cancer (NSCLC) Market Report 2026" has been added to ResearchAndMarkets.com's offering. The non-small cell lung cancer...
30. März 2026 04:31 ET | Quelle: Research and Markets

Oncology Devices: Markets and Companies Analysis Report 2026 - Eckert & Ziegler BEBIG, Oncura, GE Healthcare Lead the $210 Billion Industry; Expected to Reach $397 Billion by 2030

Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Oncology Devices Market Report 2026" has been added to ResearchAndMarkets.com's offering.The oncology devices market has witnessed significant...
24. Februar 2026 11:16 ET | Quelle: Research and Markets

Cancer Diagnostics Market Competitive Landscape Report 2025: Key Players Analysis, Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts to 2033

Dublin, Feb. 24, 2026 (GLOBE NEWSWIRE) -- The "Cancer Diagnostics Market Key Players Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future...
24. Februar 2026 11:11 ET | Quelle: Research and Markets

Lung Cancer Diagnostics Competitive Landscape Report 2025: Key Players Analysis, Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts to 2033

Dublin, Feb. 24, 2026 (GLOBE NEWSWIRE) -- The "Lung Cancer Diagnostics Market Key Players Analysis, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and...
29. Januar 2026 11:27 ET | Quelle: Research and Markets

Next Generation Cancer Diagnostics Research Report 2026 - Global Market Size, Trends, Competitive Analysis, Opportunities, and Forecasts, 2021-2025 & 2026-2031

Dublin, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The "Next Generation Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ...
29. Januar 2026 11:24 ET | Quelle: Research and Markets

Brain Cancer Diagnostics Research Report 2026 - Global Market Size, Trends, Competitive Analysis, Opportunities, and Forecasts, 2021-2025 & 2026-2031

Dublin, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The "Brain Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ...
29. Januar 2026 11:23 ET | Quelle: Research and Markets

Head and Neck Cancer Diagnostic Research Report 2026 - Global Market Size, Trends, Competitive Analysis, Opportunities, and Forecasts, 2021-2025 & 2026-2031

Dublin, Jan. 29, 2026 (GLOBE NEWSWIRE) -- The "Head and Neck Cancer Diagnostic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ...
22. Januar 2026 12:00 ET | Quelle: 4D Path

4D Path Joins Phase II Clinical Trial to Advance Predictive Biomarkers in Bladder Cancer

4D Path to participate as exploratory biomarker collaborator in Phase II DAD-IO clinical study (NCT04724018) led by DFCI and supported by Gilead Sciences

Nächste Seite